» Articles » PMID: 20060164

Mesenchymal Stem Cells in Human Placental Chorionic Villi Reside in a Vascular Niche

Overview
Journal Placenta
Publisher Elsevier
Date 2010 Jan 12
PMID 20060164
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The chorionic villi of human term placentae are a rich source of mesenchymal stem cells (PMSCs). The stem cell "niche" within the chorionic villi regulates how PMSCs participate in placental tissue generation, maintenance and repair, but the anatomic location of the niche has not been defined. A number of cell surface markers for phenotypic characterisation of mesenchymal stem cells (MSCs) were employed to identify the stem cell niche within the chorionic villi of first trimester and term human placenta. This included antibodies to pericyte cell surface markers STRO-1 and 3G5, which have been used to identify mesenchymal stem cells in other tissues, but have not been studied in placental tissues. PMSCs were isolated from term human placentae and shown to have stem cell properties by their ability to grow on untreated plastic culture ware, capacity for forming clones (i.e. clonogenicity) and their capability to differentiate into adipocytes, chondrocytes and osteocytes. Western analysis confirmed that STRO-1 and 3G5 are present in placental protein extracts and in PMSCs. Immunocytochemistry revealed PMSCs were positive for MSC cell surface markers (STRO-1, 3G5, CD105, CD106, CD146, CD49a, alpha-SMA) and negative for haematopoietic stem cell markers (CD117, CD34) and endothelial markers (CD34, vWF). Immunohistochemistry with antibodies to MSC cell surface markers on first trimester and term tissues revealed a vascular niche for PMSCs. Dual-label immunofluorescence analysis was used to compare STRO-1 antibody staining with that of endothelial cell marker vWF and found no significant overlap in staining. This indicated that some PMSCs have a pericyte-like phenotype. We propose that the vascular niche harbours a pool of PMSCs that can give rise to committed progenitors for tissue maintenance and repair, and that PMSCs contribute to vessel maturation and stabilization.

Citing Articles

Trained mesenchymal stromal cell-based therapy HXB-319 for treating diffuse alveolar hemorrhage in a pristane-induced murine model.

Bukulmez H, Dennis A, Reese-Koc J, Sieg S, Clagett B, Kleinsorge-Block S Stem Cells. 2024; 43(2).

PMID: 39560076 PMC: 11878545. DOI: 10.1093/stmcls/sxae078.


Exosomes: compositions, biogenesis, and mechanisms in diabetic wound healing.

Li Y, Zhu Z, Li S, Xie X, Qin L, Zhang Q J Nanobiotechnology. 2024; 22(1):398.

PMID: 38970103 PMC: 11225131. DOI: 10.1186/s12951-024-02684-1.


In Vitro Cell Surface Marker Expression on Mesenchymal Stem Cell Cultures does not Reflect Their Ex Vivo Phenotype.

Cao Y, Boss A, Bolam S, Munro J, Crawford H, Dalbeth N Stem Cell Rev Rep. 2024; 20(6):1656-1666.

PMID: 38837115 PMC: 11319515. DOI: 10.1007/s12015-024-10743-1.


Plasma Redox Balance in Advanced-Maternal-Age Pregnant Women and Effects of Plasma on Umbilical Cord Mesenchymal Stem Cells.

Grossini E, Aquino C, Venkatesan S, Troia L, Tizzoni E, Fumagalli F Int J Mol Sci. 2024; 25(9).

PMID: 38732088 PMC: 11084157. DOI: 10.3390/ijms25094869.


DNA methylation profiles reveal sex-specific associations between gestational exposure to ambient air pollution and placenta cell-type composition in the PRISM cohort study.

Saddiki H, Zhang X, Colicino E, Wilson A, Kloog I, Wright R Clin Epigenetics. 2023; 15(1):188.

PMID: 38041176 PMC: 10693032. DOI: 10.1186/s13148-023-01601-x.